[PDF] cmajopen.ca

Treatment for mild cognitive impairment: a systematic review and meta-analysis

D Fitzpatrick-Lewis, R Warren, MU Ali… - … Open Access Journal, 2015 - cmajopen.ca
Background: The effectiveness of treatments for mild cognitive impairment is uncertain. The
aim of this review was to evaluate the effectiveness and harms of treatment for mild cognitive …
Save Cite Cited by 91 Related articles All 12 versions Library Search Cached
[PDF] plos.org

Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials

R Raschetti, E Albanese, N Vanacore… - PLoS medicine, 2007 - journals.plos.org
Background Mild cognitive impairment (MCI) refers to a transitional zone between normal
ageing and dementia. Despite the uncertainty regarding the definition of MCI as a clinical …
Save Cite Cited by 447 Related articles All 17 versions Cached
[HTML] nih.gov

The diagnosis and management of mild cognitive impairment: a clinical review

KM Langa, DA Levine - Jama, 2014 - jamanetwork.com
Importance Cognitive decline is a common and feared aspect of aging. Mild cognitive
impairment (MCI) is defined as the symptomatic predementia stage on the continuum of …
Save Cite Cited by 1363 Related articles All 12 versions

Efficacy and safety of cholinesterase inhibitors for mild cognitive impairment: a systematic review and meta-analysis

S Matsunaga, H Fujishiro… - Journal of Alzheimer's …, 2019 - content.iospress.com
Background: The clinical benefit of cholinesterase inhibitors (ChEIs) for mild cognitive
impairment (MCI) remains inconclusive. Objective: We performed a systematic review and …
Save Cite Cited by 81 Related articles All 7 versions
[PDF] cambridge.org

Treatment for mild cognitive impairment: systematic review

C Cooper, R Li, C Lyketsos… - The British Journal of …, 2013 - cambridge.org
BackgroundMore people are presenting with mild cognitive impairment (MCI), frequently a
precursor to dementia, but we do not know how to reduce deterioration. AimsTo …
Save Cite Cited by 285 Related articles All 13 versions
[HTML] nih.gov

[HTML][HTML] A systematic review of treatments for mild cognitive impairment

C Cooper, R Li, C Lyketsos… - The British journal of …, 2013 - ncbi.nlm.nih.gov
Background More people are presenting with mild cognitive impairment (MCI), frequently a
precursor to dementia but we do not know how to reduce deterioration. Aims To …
Save Cite Cited by 26 Related articles All 2 versions
[PDF] cmaj.ca

Efficacy and safety of cognitive enhancers for patients with mild cognitive impairment: a systematic review and meta-analysis

AC Tricco, C Soobiah, S Berliner, JM Ho, CH Ng… - Cmaj, 2013 - Can Med Assoc
Background: Cognitive enhancers, including cholinesterase inhibitors and memantine, are
used to treat dementia, but their effectiveness for mild cognitive impairment is unclear. We …
Save Cite Cited by 233 Related articles All 18 versions Cached

A systematic review and network meta-analysis comparing various non-pharmacological treatments for older people with mild cognitive impairment

Y Wang, X Wang, L Chen, Y Liu, Y Li - Asian Journal of Psychiatry, 2023 - Elsevier
Abstract Background and Objective Non-pharmacological therapy appeared to alleviate Mild
Cognitive Impairment (MCI) symptoms and signs, according to systematic studies. This …
Save Cite Cited by 2 Related articles All 2 versions
[HTML] nih.gov

Cholinesterase inhibitors for mild cognitive impairment

TC Russ, JR Morling - Cochrane Database of Systematic …, 2012 - cochranelibrary.com
Cholinesterase inhibitors for mild cognitive impairment - Russ, TC - 2012 | Cochrane Library
Skip to Content Cookies Our site uses cookies to improve your experience. You can find out …
Save Cite Cited by 288 Related articles All 8 versions
[PDF] academia.edu

To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer's disease

BS Diniz, JA Pinto, MLC Gonzaga… - European archives of …, 2009 - Springer
Background Individual randomized clinical trials (RCTs) with cholinesterase inhibitors
(ChEIs) aiming to delay the progression from mild cognitive impairment (MCI) to Alzheimer's …
Save Cite Cited by 99 Related articles All 16 versions